📰 **Eli Lilly Reports Positive Phase 3b Data For Zepbound And Foundaya In Weight-Loss Maintenance **

(RTTNews) - Eli Lilly & Company (LLY) on Wednesday reported positive results from its Phase 3b SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN studies for Foundaya and lower-dose Zepbound in maintenance of weight loss.

🔗 https://www.nasdaq.com/articles/eli-lilly-reports-positive-phase-3b-data-zepbound-and-foundaya-weight-loss-maintenance

#markets #news